Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial
Clinical trial NCT07050524 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07050524
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.